The effect of vertical sleeve gastrectomy on a rat model of polycystic ovarian syndrome

Endocrinology

Volumn 152, Issue 10, 2011, Pages 3700-3705

  Wilson Pérez, Hilary E ^a   Seeley, Randy J ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; FOOD INTAKE; GASTRECTOMY; GLUCOSE TOLERANCE; LIPID METABOLISM; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RAT; VERTICAL SLEEVE GASTRECTOMY; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; FEMALE; GASTRECTOMY; MALE; POLYCYSTIC OVARY SYNDROME; RATS; RATS, WISTAR; WEIGHT LOSS;

EID: 80053169261     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1241     Document Type: Article

References (33)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749 (Pubitemid 38766360)
2. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R 2002 Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26:883-896 (Pubitemid 34756169)
3. Wild S, Pierpoint T, Jacobs H, McKeigue P 2000 Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil 3:101-105
4. Dahlgren E, Janson PO, Johansson S, Lapidus L, Odén A 1992 Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71:599-604 (Pubitemid 23050339)
5. Burghen GA, Givens JR, Kitabchi AE 1980 Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50:113-116 (Pubitemid 10203585)
6. Dunaif A, Finegood DT 1996 β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:942-947 (Pubitemid 26083951)
7. Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N 2010 Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 24:1005-1010
8. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK 2008 Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247:401-407
9. Peterli R, Wölnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, Drewe J, Von Flüe M, Beglinger C 2009 Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 250:234-241
10. Eid GM, Cottam DR, Velcu LM, Mattar SG, Korytkowski MT, Gosman G, Hindi P, Schauer PR 2005 Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis 1:77-80
11. Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, Sancho J, San Millán JL 2005 The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 90:6364-6369
12. Stefater MA, Pérez-Tilve D, Chambers AP, Wilson-Pérez HE, Sandoval DA, Berger J, Toure M, Tschöp M, Woods SC, Seeley RJ 2010 Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 138:2426-2436, 2436e1-3
13. Pereferrer FS, Gonzàlez MH, Rovira AF, Blasco SB, Rivas AM, Del Castillo Déjardin D 2008 Influence of sleeve gastrectomy on several experimental models of obesity: metabolic and hormonal implications. Obes Surg 18:97-108
14. Chambers A, Jessen L, Ryan K, Sisley S, Wilson-Pérez H, Stefater M, Gaitonde S, Sorrell J, Toure M, Berger J, D'Alessio D, Woods S, Seeley R, Sandoval D 06 June 2011 Weight-independent changes in blood glucose homeostasis after Roux-en-Y gastric bypass and vertical sleeve gastrectomy surgeries in rats. Gastroenterology 10.1053/j.gastro.2011.05.050
15. Abbott DH, Zhou R, Bird IM, Dumesic DA, Conley AJ 2008 Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome. Endocr Dev 13:145-158
16. Birch RA, Padmanabhan V, Foster DL, Unsworth WP, Robinson JE 2003 Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep. Endocrinology 144:1426-1434 (Pubitemid 36428485)
17. Mannerås L, Cajander S, Holmäng A, Seleskovic Z, Lystig T, Lönn M, Stener-Victorin E 2007 A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 148:3781-3791 (Pubitemid 47105840)
18. Demissie M, Lazic M, Foecking EM, Aird F, Dunaif A, Levine JE 2008 Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. Am J Physiol Endocrinol Metab 295:E262-E268
19. Feng Y, Johansson J, Shao R, Mannerås L, Fernandez-Rodriguez J, Billig H, Stener-Victorin E 2009 Hypothalamic neuroendocrine functions in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture. PLoS One 4:e6638
20. Stefater M, Sandoval D, Chambers A, Wilson-Perez H, Hofmann S, Jandacek R, Tso P, Woods S, Seeley R 19 May 2011 Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. Gastroenterology 10.1053/j.gastro.2011.05.008
21. Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt W 2003 Beyond adrenal and ovarian androgen generation: increased peripheral 5 α-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2760-2766 (Pubitemid 36724453)
22. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS, Oberfield SE 2003 Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88:4682-4688 (Pubitemid 37357512)
23. Becker JB, Arnold AP, Berkley KJ, Blaustein JD, Eckel LA, Hampson E, Herman JP, Marts S, Sadee W, Steiner M, Taylor J, Young E 2005 Strategies and methods for research on sex differences in brain and behavior. Endocrinology 146:1650-1673 (Pubitemid 40396871)
24. Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbely Y, Beglinger C 11 February 2011 Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial. Surg Obes Relat Dis 10.1016/j.soard.2011.01.044
25. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43:647-654 (Pubitemid 24145474)
26. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M,Zanolin E, Muggeo M 2000 Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85:139-146 (Pubitemid 32268804)
27. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L 2002 Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 17:2858-2864 (Pubitemid 35350902)
28. Johansson J, Feng Y, Shao R, Lönn M, Billig H, Stener-Victorin E 2010 Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome. Am J Physiol Endocrinol Metab 299:E551-E559
29. Mannerås L, Cajander S, Lönn M, Stener-Victorin E 2009 Acupuncture and exercise restore adipose tissue expression of sympathetic markers and improve ovarian morphology in rats with dihydrotestosterone-induced PCOS. Am J Physiol Regul Integr Comp Physiol 296:R1124-R1131
30. Moran LJ, Hutchison SK, Norman RJ, Teede HJ 2011 Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2:CD007506
31. Nieuwenhuis-Ruifrok AE, Kuchenbecker WK, Hoek A, Middleton P, Norman RJ 2009 Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis. Hum Reprod Update 15:57-68
32. De Leo V, Musacchio MC, Palermo V, Di Sabatino A, Morgante G, Petraglia F 2009 Polycystic ovary syndrome and metabolic comorbidities: therapeutic options. Drugs Today 45:763-775
33. Mannerås L, Jonsdottir IH, Holmäng A, Lönn M, Stener-Victorin E 2008 Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome. Endocrinology 149:3559-3568 (Pubitemid 351919588)